National
LGBT staffer group returns to Capitol Hill
‘We’re going to be building relationships’

Members of the newly re-launched LGBT Congressional Staff Association intend to focus on networking and behind-the-scenes policy work. (Washington Blade photo by Michael Key)
Openly gay staffers on Capitol Hill could find new opportunities to network and advance pro-gay legislation now that an LGBT staff association has returned following a period of dormancy.
The group, named the LGBT Congressional Staff Association, seeks to facilitate communication among LGBT staffers working for members of the U.S. House of Representatives.
Scott Simpson, deputy press secretary for Rep. Marcia Fudge (D-Ohio), officially took the reins of the organization Monday after dues-paying members voted him and other new board members into leadership roles.
In a Blade interview, Simpson, who’s 26 and gay, said the organization plans to take a low-profile approach to advance the needs of LGBT staffers and advance pro-LGBT policy in Congress.
“We’re uniquely positioned to work with a targeted audience and work with however many hundreds of Hill staffers we can find,” he said. “We’re not going to be out there trying to get the [Washington] Post to quote us or anything; we’re going to be building relationships.”
The group’s re-launch comes after an earlier version of the organization was founded about 15 years ago.
Simpson said the group — previously known as the Gay & Lesbian Congressional Staff Association — was founded to draw attention to the presence of LGBT staffers on the Hill.
“It was a very big deal, at least for us, on the Hill when it got started,” Simpson said. “It did a lot of good stuff for visibility at the time when there were some congressmen who outright said, ‘We would never hire a gay staffer.’”
Simpson said the LGBT Congressional Staff Association responded at the time by having press conferences to “show that there are actually LGBT people” who work on Capitol Hill.
In recent years, Simpson said the organization had the appearance of being dormant because it was continuing a commitment made when it was founded of protecting the identities of members who weren’t openly gay.
“They wanted that soft influence on policy and they wanted to protect the identities of their staffers, and that doesn’t lend itself to being the most vocal organization,” he said.
But Simpson said LGBT staffers on the Hill in recent months wanted to give new life to the organization, to make it more open and “continue on with the legacy of breaking barriers” that emerged when the association was founded.
Simpson said the group has been in the process of being reinvented for the past three to six months and, as part of its re-launch, tweaked its bylaws and took on the LGBT Congressional Staff Association name.
New goals for the organization include developing a web site and forming a women’s caucus that will have its own specific programming.
The organization’s membership varies widely depending on how it’s counted. Simpson said there are about 50 dues-paying members, but 400 are registered on the group’s e-mail list. One task the organization is considering, Simpson noted, is some type of “census” to determine how many LGBT staffers work on the Hill.
Simpson said the number of LGBT people working as Capitol Hill staffers might surprise those living outside the Beltway. He also noted that LGBT staffers “don’t line up with any particular caucus,” and can be found working with either Democratic or Republican members.
“There are a lot of LGBT staffers on the Hill and that’s a strength that we can tap into,” he said.
Some established and notable LGBT staffers comprise the LGBT Congressional Staff Association board. Diego Sanchez, who’s transgender and senior legislative adviser to Rep. Barney Frank (D-Mass.), will serve as policy director for the organization.
In a statement to the Blade, Sanchez said he’s honored to be the first openly transgender board member of the re-launched organization.
“The new bylaws and my corporate career expertise in diversity management will let me lead and work with my staffer colleagues to fortify how current laws and issues affect us and to repair any gaps to enrich the lives and careers of current and future LGBT people working on the Hill,” he said.
Group will work to influence LGBT policy
Simpson said the organization would work to influence LGBT policy matters related to bills on Capitol Hill, such as the Employment Non-Discrimination Act and repeal of “Don’t Ask, Don’t Tell.”
He said he wants to network with LGBT staffers to educate them on the issues and expand the number of co-sponsors on those bills.
“We’re going to be doing training and education on that,” he said. “We want to make sure that we are connecting and networking as many of these gay staffers in every office, in every party across geography to know what’s up.”
Simpson said one bill his organization is particularly pushing is the Domestic Partnership Benefits & Obligations Act. The legislation would make same-sex partners of federal workers eligible for the same benefits available to the spouses of straight workers, including health and pension benefits.
Repealing the Defense of Marriage Act, a move that would allow the federal government to recognize same-sex marriages, is another issue in which Simpson said his organization would be involved. With same-sex marriage now legal in D.C., he noted that many LGBT staffers are able to marry and want the federal benefits associated with marriage.
“Those directly affect our members because the federal government is prohibited from recognizing the validity of our relationships,” he said.
Additionally, Simpson said a goal of the organization is advancing the careers of LGBT staffers so they can serve in positions that give them more influence to move pro-LGBT legislation through Congress.
“If a job opens up that someone wants, we’re going to get together to use our network as a group to figure out how we can best get the person in this position, if they’re qualified for it,” he said.
But group activities won’t be all work. Simpson said networking opportunities would also include recreational events, such as happy hours.
“A lot of it is getting together and going to happy hours, just meeting and greeting, even in a non-drinking setting, believe it or not,” he said.
Elected officials have been helping re-launch the LGBT Congressional Staff Association. The openly gay members of Congress — Reps. Barney Frank (D-Mass.), Tammy Baldwin (D-Wis.) and Jared Polis (D-Colo.) — have sponsored the organization as an official staff group.
In a statement, Baldwin said she’s proud to sponsor the organization because LGBT staffers work in many capacities on the Hill for members of both parties.
“I’m very pleased to support this new iteration of the LGBT staff association,” she said. “In addition to serving as a networking and social group, this organization will help us advocate for more equitable policies in and out of government.”
Simpson said the out members of Congress aren’t technically eligible to become members of the organization because they aren’t staffers. Still, he noted that their sponsorship makes the group able to use the U.S. House web servers and e-mail system.
“If not for them, the organization wouldn’t exist,” he said. “If we need anything, we go to them because they’re our members.”
Simpson said he expects the LGBT Congressional Staff Association to have a collaborative relationship with the Gay, Lesbian & Allies Senate Staff Caucus, the affinity group for LGBT staffers working in the U.S. Senate.
Among the events in which both groups would plan joint participation are social and educational activities as well as marching in the same contingent next month during the Capital Pride parade.
“I’ve been talking with them,” Simpson said. “They’ve been helping us organize this newer reinvention for a while, so we’ve been very close.”
Alex Levy, co-chair of GLASS and legislative aide to Sen. Chuck Schumer (D-N.Y.), said his organization is “thrilled” to have the opportunity to collaborate with another LGBT group.
“They have lots of energy and it looks to be a dynamic leadership team, and we intend to work collaboratively with them to work for the interests of LGBT Hill staffers,” Levy said.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
